SWEDISH ORP BIO Current Ratio 1970-1969 | BIOVF
Current and historical current ratio for SWEDISH ORP BIO (BIOVF) from 1970 to 1969. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. SWEDISH ORP BIO current ratio for the three months ending December 31, 1969 was 0.00.
|SWEDISH ORP BIO Current Ratio Historical Data
||Medical - Biomedical and Genetics
Swedish Orphan Biovitrum is a biotechnology company. It develops, manufactures and sells medications within hemophilia, autoimmune diseases, metabolic diseases and cancer supportive care. The Company's product portfolio consists of Core Products segment which offers pharmaceuticals within Inflammation area and Genetics and metabolic therapeutic area; Partner Products segment which offers pharmaceuticals within hematology, oncology and emergency medicines, and the ReFacto Manufacturing segment. The company operates primarily in Sweden, Denmark, Finland, Norway, United Kingdom and France. Swedish Orphan Biovitrum is based in Solna, Sweden.